NIH expands clinical trials to test convalescent plasma against COVID-19
(World News Science)

News Release Tuesday, September 22, 2020 NIH expands clinical trials to test convalescent plasma against COVID-19 Rigorous studies to build on earlier efforts to test the experimental treatment Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19. Preliminary observational studies indicate that convalescent plasma may improve outcomes among severely ill and hospitalized patients with COVID-19. Prospective, well-controlled randomized trials are needed to generate sufficient data on whether convalescent plasma is effective and...